QGEN:NYSE
Qiagen NV
$45.31
arrow_downward
-0.15%(-0.070) 1D
$45.75
arrow_upward
+0.97% (+0.44)todayPre-market
Closed: Oct 12, 4:00:06 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QGEN...
Open
$45.68
High
$45.69
Low
$44.96
Mkt. cap
9.36B
Avg. vol.
2.07M
Volume
1.02K
Dividend
0.77%
Quarterly dividend
$0.09
Ex-dividend date
Jul 7, 2026
P/E ratio
23.31
52-wk high
$57.82
52-wk low
$32.53
EPS
$1.94
Beta
0.61
Shares outstanding
206.08M
No. of employees
6K
Open
$45.68
High
$45.69
Low
$44.96
Mkt. cap
9.36B
Avg. vol.
2.07M
Volume
1.02K
Dividend
0.77%
Quarterly dividend
$0.09
Ex-dividend date
Jul 7, 2026
P/E ratio
23.31
52-wk high
$57.82
52-wk low
$32.53
EPS
$1.94
Beta
0.61
Shares outstanding
206.08M
No. of employees
6K
News stories
From web sources and news partners
Simply Wall Street
·
11 hours ago
Did AI Research Tools Just Shift Qiagen's (QGEN) Investment Narrative?
ad-hoc-news.de
·
1 day ago
BofA raises target for Qiagen stock from USD 49 to USD 50
Profile
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer. Wikipedia
About Qiagen NV
CEOThierry Bernard
Employees5.5K
FoundedNov 29, 1984
HeadquartersVenlo, Limburg, Netherlands
SectorHealth care
Websiteqiagen.com